In this study, hsa-miR-203a-3p was predicted to regulate TNF and CCR5, suggesting that miRNAs might affect the progression of gout as well as atherosclerosis by modulating the expression of these key inflammatory and immune-related genes. The gene discussed is CCR5; the disease is gout.